George M. Milne Jr. - 06 Jan 2022 Form 4 Insider Report for Amylyx Pharmaceuticals, Inc. (AMLX)

Role: Director
Signature: /s/ Joshua B. Cohen, as Attorney in Fact for George Mclean Milne
Issuer symbol: AMLX
Transactions as of: 06 Jan 2022
Net transactions value: +$499,985
Form type: 4
Filing time: 10 Jan 2022, 19:34:15 UTC
Previous filing: 16 Jun 2021
Next filing: 08 Mar 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AMLX	Common Stock	Purchase	$499,985	+26,315	+13%	$19.00	221,396	06 Jan 2022	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	AMLX	Stock Option (Right to Buy)	Award	$0	+8,400		$0.000000	8,400	06 Jan 2022	Common Stock	8,400	$19.00	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This option shall vest in full on the date of the Corporation's 2022 Annual Stockholders Meeting, subject to the Reporting Person's continuous service to the Issuer through such vesting date.